High risk of new episode of symptomatic vasospasm in unaffected arteries in subarachnoid hemorrhage patients receiving targeted endovascular treatment for symptomatic focal vasospasm

Neurocritical Care

Volumn 20, Issue 3, 2014, Pages 399-405

  Tekle, Wondwossen G ^a   Chaudry, Saqib A ^a   Hassan, Ameer E ^a   Qaiser, Habib ^a   Grigoryan, Mikayel ^a   Rodriguez, Gustavo J ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aneurysm; Angioplasty; Intra arterial vasodilators; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

MAGNESIUM SULFATE; NICARDIPINE; NIMODIPINE; VASODILATOR AGENT; VERAPAMIL;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON CATHETER; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; ANGIOPLASTY; BRAIN ARTERY; CEREBRAL REVASCULARIZATION; DRUG EFFECTS; INTENSIVE CARE; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; RECURRENT DISEASE; RISK FACTOR; VASOSPASM, INTRACRANIAL;

ADULT; ANGIOPLASTY; CEREBRAL ARTERIES; CEREBRAL REVASCULARIZATION; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INTENSIVE CARE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84902366058     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9825-2     Document Type: Article

References (20)

1. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1. Overall management results. J Neurosurg. 1990;73:18-36. (Pubitemid 20206379)
2. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636-42. (Pubitemid 19088521)
3. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol. 1983;14:599-608. (Pubitemid 14211605)
4. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998;42:510-6. discussion 516-7.
5. Higashida RT, Halbach VV, Cahan LD, Brant-Zawadzki M, Barnwell S, Dowd C, Hieshima GB. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg. 1989;71:648-53. (Pubitemid 19275760)
6. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;92:284-90. (Pubitemid 30071048)
7. McGuinness B, Gandhi D. Endovascular management of cerebral vasospasm. Neurosurg Clin N Am. 2010;21(2):281-90.
8. Connolly ES Jr, Rabinstein AA, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711-37.
9. Sehy JV, Holloway WE, Lin SP, Cross DT 3rd, Derdeyn CP, Moran CJ. Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration. AJNR Am J Neuroradiol. 2010;31(10):1923-8.
10. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2000;31(7):1621-7. (Pubitemid 30437513)
11. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998;42(3):510-6. Discussion 516-7.
12. Shah QA, Memon MZ, Suri MF, Rodriguez GJ, Kozak OS, Taylor RA, Tummala RP, Vazquez G, Georgiadis AL, Qureshi AI. Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):190-8.
13. Lazaridis C, Naval N. Risk factors and medical management of vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21(2):353-64.
14. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(11):1761-70.
15. Pradilla G, Chaichana KL, Hoang S, Huang J, Tamargo RJ. Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21(2):365-79.
16. Jordan JD, Nyquist P. Biomarkers and vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21(2):381-91.
17. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST. The prophylactic use of transluminal balloon angioplasty in patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg. 1999;91:51-8.
18. Megyesi JF, Findlay JM, Vollrath B, Cook DA, Chen MH. In vivo angioplasty prevents the development of vasospasm in canine carotid arteries: pharmacological and morphological analyses. Stroke. 1997;28:1216-24. (Pubitemid 27248900)
19. Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK, Smith K, Eskridge J, Newell D, Verweij B, Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39(6):1759-65.
20. Akins PT, Axelrod Y, Arshad S, Hartman J, Ji C, Ciporen J, Hawk MW. Comprehensive stroke center treatment and outcomes for elderly adults with cerebral aneurysms and subarachnoid hemorrhage. J Am Geriatr Soc. 2012;60(10):1984-6.